Los Altos, CA, United States of America

Brian Russell Wong

This inventor holds 1 USPTO granted patent. Top assignee: Rapt Therapeutics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Russell Wong. Retrieved from https://idiyas.com/inventor/brian-russell-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Russell Wong: Innovator in Anticancer Therapeutics

Introduction

Brian Russell Wong is a notable inventor based in Los Altos, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.

Latest Patents

Brian holds a patent for anticancer agents, specifically focusing on therapeutic methods that administer compounds modulating the C-C chemokine receptor type 4 (CCR4). This patent addresses the treatment of Epstein-Barr virus (EBV) positive cancers and malignancies. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Brian is currently associated with Rapt Therapeutics, Inc., where he continues to work on groundbreaking therapies. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative cancer treatments.

Collaborations

Brian has worked alongside talented individuals such as Gene Cutler and William Yew-Wai Ho. These collaborations have further enriched his research and development efforts in the field of oncology.

Conclusion

Brian Russell Wong is a dedicated inventor whose work in anticancer therapeutics is making a significant impact in the medical field. His innovative approaches and collaborations are paving the way for new treatment options for patients facing challenging cancers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…